Over-D1 dissection may question the value of radiotherapy as a part of an adjuvant programme in high-risk radically resected gastric cancer patients

British Journal of Cancer

Volumn 92, Issue 6, 2005, Pages 1051-1054

  Scartozzi, M ^a   Galizia, E ^a   Graziano, F ^b   Catalano, V ^c   Berardi, R ^a   Baldelli, A M ^c   Testa, E ^b   Mari, D ^d   Silva, R R ^d   Cascinu, S ^a,e  

^a OSPEDALI RIUNITI   (Italy)

^b Ospedale di Urbino   (Italy)

^c SAN SALVATORE HOSPITAL   (Italy)

^d Ospedale di Fabriano   (Italy)

^e Azienda Ospedaliera Umberto I   (Italy)

Author keywords

Adjuvant radiochemotherapy; Gastric cancer; Lymphadenectomy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HIGH RISK PATIENT; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH CANCER; SURVIVAL TIME; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; STOMACH TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; STOMACH NEOPLASMS;

EID: 20244383168     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602468     Document Type: Article

References (24)

1. Alberts SR, Cervantes A, van de Velde CJH (2003) Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 14(S2): ii31-ii36
2. Bonenkamp JJ, Hermans J, Sasako M, van de Velde CJ (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340: 908-914
3. Bouvier AM, Haas O, Piard F, Roignot P, Bonithon-Kopp C, Faivre J (2002) How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study. Cancer 94: 2862-2866
4. Bozzetti F, Marubini E, Bonfanti G, Miceli R, Piano C, Crose N, Gennari L (1997) Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group. Ann Surg 226: 613-620
5. Cox DR (1972) Regression models and life-tables. J R Stat Soc 34: 187-220
6. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Payers P (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomised surgical trial: Surgical Co-operative Group. Br J Cancer 79: 1522-1530
7. Davis PA, Sano T (2001) The difference in gastric cancer between Japan, USA and Europe: what are the facts? What are the suggestions? Crit Rev Oncol/Hematol 40: 77-94
8. Gunderson LL (2002) Gastric cancer-patterns of relapse after surgical resection. Semin Radiat Oncol 12: 150-161
9. Hohenberger P, Gretschel S (2003) Gastric cancer. Lancet 362: 305-315
10. Hundahl SA, Macdonald JS, Benedetti J, Fitzsimmons T, Southwest Oncology Group, Gastric Intergroup (2002) Surgical treatment variation in a prospective, randomised trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol 9: 278-286
11. Jemal A, Thomas A, Murray T, Thun M (2002) Cancer statistics 2002. CA Cancer J Clin 52: 23-47
12. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
13. Kim HJ, Karpeh MS (2002) Surgical approaches and outcomes in the treatment of gastric cancer. Semin Radiat Oncol 12: 162-169
14. Lewis WG, Edwards P, Barry JD, Khan S, Dhariwal D, Hodzovic I, Allison MC, Shute K (2002) D2 or not D2? The gastrectomy question. Gastric Cancer 5: 29-34
15. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345: 725-730
16. Marubini E, Bozzetti F, Miceli R, Bonfanti G, Gennari L, The Italian Gastrointestinal Tumour Study Group (2002) Lymphadenectomy in gastric cancer: prognostic role and therapeutic implications. Eur J Surg Oncol 28: 406-412
17. Nitti D, Marchet A, Olivieri M, Ambrosi A, Mencarelli R, Farinati F, Belluco C, Lise M (2003) Lymphadenectomy in patients with gastric cancer: a critical review. Tumori 2(Suppl 2): S35-S38
18. Park SH, Kim DY, Heo JS, Lim DH, Park CK, Lee KW, Choi SH, Sohn TS, Kim S, Noh JH, Kim YI, Park JO, Kim K, Kim WS, Jung CW, Im YH, Lee MH, Park K, Park CH, Kang WK (2003) Postoperative chemoradiotherapy for gastric cancer. Ann Oncol 14: 1373-1377
19. Reis E, Kama NA, Doganay M, Atli M, Dolapci M (2002) Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer. Hepatogastroenterology 49: 1167-1171
20. Sierra A, Regueira FM, Hernandez-Lizoain JL, Pardo F, Martinez-Gonzalez MA, A-Cienfuegos J (2003) Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol 10: 219-226
21. Siewert JR, Bottcher K, Stein HJ, Roder JD, The German Gastric Carcinoma Study Group (1998) Relevant prognostic factors in gastric cancer. Ten-years results of the German gastric cancer study. Ann Surg 228: 449-461
22. Sobin LH, Wittekind CH (eds) (1997) TNM Classification of Malignant Tumors, 5th edition, International Union Against Cancer (UICC) pp 59-65. New York: Wiley
23. van de Velde CJH, Peeters KCMJ (2003) The gastric cancer treatment controversy. J Clin Oncol 21: 2234-2236, (Editorial)
24. Wagner P, Ramaswamy A, Ruschoff J, Schmitz-Moormann P, Rothmund M (1991) Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer. Br J Surg 78: 825-827